Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by narmacon Jun 27, 2022 8:06pm
100 Views
Post# 34786110

RE:NASDAQ Listing

RE:NASDAQ ListingHummm,,,,like the idea,,,,and I think an assumption will be made by Mr Market in respect to what the market cap should look like based on where we are with our science and what risk is inherent in the assumption,,,,if we actually do make it to the NASDAQ it is assumed a speculative market cap would be assigned and adjusted accordingly, as deals and licenses and trial adavancements come into the market play. If we do meet up with real investors willing to buy risk we could move up substatially,,,Jmo...
<< Previous
Bullboard Posts
Next >>